Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Mengel

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Neurology and Therapy|May 27, 2026
Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol ComparisonRoger Plaza-Clar, Maximilian Weber, Vaibhavi Kadam, et al.
Parkinsonism & Related Disorders|December 15, 2015
TREM2 rare variant p.R47H is not associated with Parkinson's diseaseDavid Mengel, Mathias Thelen, Monika Balzer-Geldsetzer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 1, 2023
Fc N-glycosylation of autoreactive Aβ antibodies as a blood-based biomarker for Alzheimer's diseaseYannick Kronimus, Alexandra Albus, Mike Hasenberg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2018
Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's diseaseZhicheng Chen, David Mengel, Ashvini Keshavan, et al.
European Journal of Neurology|April 16, 2025
High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification ProtocolsStefan Bräuer, Maximilian Weber, Christian Deuschle, et al.
Plos One|July 14, 2015
Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's DiseaseJan-Philipp Bach, Maike Gold, David Mengel, et al.
Ebiomedicine|April 24, 2025
The genetic landscape of sporadic adult-onset degenerative ataxia: a multi-modal genetic study of 377 consecutive patients from the longitudinal multi-centre SPORTAX cohortDanique Beijer, David Mengel, Demet Önder, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 25, 2023
Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult-Onset Degenerative AtaxiaDemet Oender, Jennifer Faber, Carlo Wilke, et al.
BMC Medicine|March 25, 2026
Digenic inheritance of mutations in SPG7 and AFG3L2 causes motor neuron and cerebellar disordersMehrdad A Estiar, Eric Yu, Parizad Varghaei, et al.
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Neurology and Therapy|May 27, 2026
Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol ComparisonRoger Plaza-Clar, Maximilian Weber, Vaibhavi Kadam, et al.
Parkinsonism & Related Disorders|December 15, 2015
TREM2 rare variant p.R47H is not associated with Parkinson's diseaseDavid Mengel, Mathias Thelen, Monika Balzer-Geldsetzer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 1, 2023
Fc N-glycosylation of autoreactive Aβ antibodies as a blood-based biomarker for Alzheimer's diseaseYannick Kronimus, Alexandra Albus, Mike Hasenberg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2018
Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's diseaseZhicheng Chen, David Mengel, Ashvini Keshavan, et al.
European Journal of Neurology|April 16, 2025
High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification ProtocolsStefan Bräuer, Maximilian Weber, Christian Deuschle, et al.
Plos One|July 14, 2015
Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's DiseaseJan-Philipp Bach, Maike Gold, David Mengel, et al.
Ebiomedicine|April 24, 2025
The genetic landscape of sporadic adult-onset degenerative ataxia: a multi-modal genetic study of 377 consecutive patients from the longitudinal multi-centre SPORTAX cohortDanique Beijer, David Mengel, Demet Önder, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 25, 2023
Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult-Onset Degenerative AtaxiaDemet Oender, Jennifer Faber, Carlo Wilke, et al.
BMC Medicine|March 25, 2026
Digenic inheritance of mutations in SPG7 and AFG3L2 causes motor neuron and cerebellar disordersMehrdad A Estiar, Eric Yu, Parizad Varghaei, et al.
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
Pageof 6